nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Airway clearance therapy in the school environment: Retrospective analysis of a cohort of pediatric patients with cystic fibrosis
|
Byrwa, David J. |
|
|
22 |
5 |
p. 811-815 |
artikel |
2 |
Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis
|
Mésinèle, Julie |
|
|
22 |
5 |
p. 901-908 |
artikel |
3 |
A multidisciplinary model for prenatal care for patients with cystic fibrosis in the era of highly effective modulator therapy
|
Li, Susan S |
|
|
22 |
5 |
p. 806-810 |
artikel |
4 |
A paradigm shift in cystic fibrosis nutritional care: Clinicians' views on the management of patients with overweight and obesity
|
Snowball, Joanna E |
|
|
22 |
5 |
p. 836-842 |
artikel |
5 |
Association between unplanned pregnancies and maternal exacerbations in cystic fibrosis
|
Peng, Giselle |
|
|
22 |
5 |
p. 796-803 |
artikel |
6 |
Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis
|
Rosenfeld, Margaret |
|
|
22 |
5 |
p. 857-863 |
artikel |
7 |
Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial
|
Chen, Yuxin |
|
|
22 |
5 |
p. 916-925 |
artikel |
8 |
Body composition and body mass index measures from 8 to 18 years old in children with cystic fibrosis
|
Tran, Jade K. |
|
|
22 |
5 |
p. 851-856 |
artikel |
9 |
Cervical mucus quality in females with and without cystic fibrosis
|
ROE, Andrea H. |
|
|
22 |
5 |
p. 804-805 |
artikel |
10 |
Cost-effectiveness analysis of genetic tools to predict treatment response in patients with cystic fibrosis
|
Sahakyan, Yeva |
|
|
22 |
5 |
p. 933-940 |
artikel |
11 |
Drug desensitization to lumacaftor/ivacaftor: A fast lane to drug tolerance
|
Westhoff, J. |
|
|
22 |
5 |
p. 941-943 |
artikel |
12 |
Editorial Board
|
|
|
|
22 |
5 |
p. ii |
artikel |
13 |
Effects of postage on recovery of pathogens from cystic fibrosis sputum samples
|
Hatfield, Lauren |
|
|
22 |
5 |
p. 816-822 |
artikel |
14 |
Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis
|
McGarry, Meghan E. |
|
|
22 |
5 |
p. 909-915 |
artikel |
15 |
Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis
|
Licht, Johann-Christoph |
|
|
22 |
5 |
p. 888-893 |
artikel |
16 |
Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis
|
Madaule, Justine |
|
|
22 |
5 |
p. 944-948 |
artikel |
17 |
Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis
|
Blanchard, Ana C. |
|
|
22 |
5 |
p. 880-883 |
artikel |
18 |
Food for thought: The revolution stirring within nutritional care priorities in cystic fibrosis
|
Sathe, Meghana N |
|
|
22 |
5 |
p. 785-787 |
artikel |
19 |
Impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in children with cystic fibrosis
|
Schembri, L |
|
|
22 |
5 |
p. 843-846 |
artikel |
20 |
Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis
|
McElvaney, Oliver J. |
|
|
22 |
5 |
p. 875-879 |
artikel |
21 |
Investigating Pseudomonas aeruginosa population structure and frequency of cross-infection in UK cystic fibrosis clinics - a reference laboratory perspective
|
Kenna, Dervla T.D. |
|
|
22 |
5 |
p. 894-900 |
artikel |
22 |
Managing women's health in CF: the birth of new challenges
|
Cohen, Raya |
|
|
22 |
5 |
p. 783-784 |
artikel |
23 |
Mobile health platform for self-management of pediatric cystic fibrosis: Impact on patient-centered care outcomes
|
Oates, Gabriela R. |
|
|
22 |
5 |
p. 823-829 |
artikel |
24 |
News article
|
Madge, Susan |
|
|
22 |
5 |
p. 781-782 |
artikel |
25 |
Nutritional considerations for a new era: A CF foundation position paper
|
Leonard, Amanda |
|
|
22 |
5 |
p. 788-795 |
artikel |
26 |
Partners in research: The success with therapies research consortium and the CF community unite to improve self-management
|
Sawicki, Gregory S. |
|
|
22 |
5 |
p. 830-835 |
artikel |
27 |
Prevalence, Risk Factors, and Sequelae of Asymptomatic Clostridioides difficile Colonization in Children with Cystic Fibrosis
|
Reasoner, Seth A. |
|
|
22 |
5 |
p. 884-887 |
artikel |
28 |
Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations
|
Heltshe, Sonya L. |
|
|
22 |
5 |
p. 864-867 |
artikel |
29 |
Role of hyperglycemia in cystic fibrosis pulmonary exacerbations
|
Merjaneh, Lina |
|
|
22 |
5 |
p. 868-874 |
artikel |
30 |
Short-term structural and functional changes after airway clearance therapy in cystic fibrosis
|
West, Michael E. |
|
|
22 |
5 |
p. 926-932 |
artikel |
31 |
Traits, trends and hits of orphan drug designations in cystic fibrosis
|
Costa, Enrico |
|
|
22 |
5 |
p. 949-957 |
artikel |
32 |
Weight a minute: Exploring the effect on weight and body composition after the initiation of elexacaftor/tezacaftor/ivacaftor in adults with CF
|
Proud, David |
|
|
22 |
5 |
p. 847-850 |
artikel |